Evidence map›Paper›PMID 22812541›Full record

ArticleMolecular pharmaceutics2012

Role of the equilibrative and concentrative nucleoside transporters in the intestinal absorption of the nucleoside drug, ribavirin, in wild-type and Ent1(-/-) mice.

Aaron M Moss, Christopher J Endres, Ana Ruiz-Garcia, Doo-Sup Choi, Jashvant D Unadkat

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.6field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 22 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Aaron M MossDepartment of Pharmaceutics, University of Washington, Seattle, Washington 98195-7610, United States.
Christopher J Endres
Ana Ruiz-Garcia
Doo-Sup Choi
Jashvant D Unadkat
University of Washington · US

Funding

UPTAKE OF NUCLEOSIDES &NUCLEOSIDE DRUGS IN INTESTINER01GM054447 · NIGMS · UNIVERSITY OF WASHINGTON · PI UNADKAT, JASHVANT D · 1996 to 2008
$2.8M
CREB, Alcohol Reward and Consumption in ENT1 Null MiceR01AA015164 · NIAAA · MAYO CLINIC ROCHESTER · PI CHOI, DOO-SUP · 2006 to 2010
$1.3M
NIAAA NIH HHS AA015164NIAAA NIH HHS R01 AA015164NIGMS NIH HHS GM54447NIGMS NIH HHS R01 GM054447
6 · The paper itself

Abstract

Ribavirin is frontline treatment for hepatitis C virus infection. To determine the role of nucleoside transporters in the intestinal absorption of orally administered ribavirin, we perfused the intestines of Ent1(-/-) and wild-type mice, in situ, with [(3)H] ribavirin (20, 200, and 5000 μM) in the presence and absence of sodium. The decrease in luminal ribavirin concentration over 30 min was measured at 5 min intervals. Blood samples were collected approximately every 10 min. Ribavirin plus phosphorylated metabolite concentrations (hereafter referred to as ribavirin) were determined in tissue, blood, and plasma by HPLC fractionation and scintillation counting. There was no significant difference between wild-type and Ent1(-/-) mice in intestinal loss of ribavirin at any ribavirin concentration studied. Perfusions without sodium drastically reduced the intestinal loss of ribavirin in both wild-type and Ent1(-/-) mice. After 20 μM ribavirin perfusions, Ent1(-/-) intestinal tissue contained 8-fold greater ribavirin than wild-type mice (p < 0.01). Ribavirin concentrations in the wild-type intestinal tissue were 70-fold higher after 200 vs 20 μM perfusions (p < 0.001), indicating saturation of intestinal ribavirin efflux and possibly other processes as well. Ribavirin plasma concentrations were significantly higher in wild-type mice (2.7-fold) vs Ent1(-/-) mice at 30 min after the 20 μM perfusion (p < 0.01). These results suggest that, at lower intestinal concentrations of ribavirin, concentrative and equilibrative nucleoside transporters are important in the intestinal absorption of ribavirin. At higher intestinal concentrations, these transporters are saturated and other processes in the intestine (transport and/or metabolism) play an important role in the absorption of ribavirin.

Indexed as

AnimalsBiological TransportCell LineDogsEquilibrative Nucleoside Transporter 1FemaleIntestinal AbsorptionKineticsMadin Darby Canine Kidney CellsMaleMembrane Transport ProteinsMiceMice, TransgenicNucleosidesNucleoside Transport ProteinsRibavirinEquilibrative Nucleoside Transporter 1Membrane Transport ProteinsNucleosidesNucleoside Transport ProteinsRibavirinSLC29A1 protein, mouseSodium

Identifiers

PMID22812541
PMCPMC3443246
OpenAlexW1984159170

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.